About Zenithstride

Established in 2014, Zenithstride is an independent research journal committed to advancing evidence-based men's vitality, metabolic health, and longevity science.

Institutional Heritage & Mission

Zenithstride was founded over a decade ago with a single clear directive: to bridge the vast gap between high-level clinical physiological research and practical daily health habits for adult men. In an online environment saturated with aggressive commercial marketing, sensationalized fitness fads, and unsubstantiated claims, Zenithstride stands as an authoritative, peer-reviewed educational repository.

We operate under the ownership and editorial governance of UEL HOLDING AS (Organisasjonsnummer: 937 818 750), a registered Norwegian corporate entity headquartered in Nesbru, Asker municipality, Norway.

Our Core Tenets

  • Scientific Rigor: All claims are substantiated by indexed clinical studies.
  • Absolute Transparency: Zero hidden sponsor endorsements or commercial bias.
  • Practical Utility: Translating cellular physiology into accessible lifestyle cues.
  • Public Benefit: Open-access educational monographs for global readers.
Editorial office and scientific consultation

Editorial Leadership & Governance

Our editorial team brings together experienced researchers, health communicators, and operational leaders dedicated to maintaining the highest journalistic and academic standards.

Ulf Eirik Larsen

Ulf Eirik Larsen

Managing Director & Board Chairman (f. 1965)

Oversees institutional strategy, legal compliance, and long-term research initiatives across UEL HOLDING AS. Dedicated to promoting preventive health education throughout Scandinavia and international markets.

Bethany Harper

Bethany Harper

Lead Health Communications Director

Directs the editorial workflow, peer-review coordination, and plain-language synthesis of complex biochemical literature, ensuring accessibility without compromising scientific integrity.

Our 4-Stage Fact-Checking Methodology

To ensure every monograph reflects the most accurate and up-to-date scientific consensus, Zenithstride applies a rigorous four-stage evaluation pipeline prior to release:

  1. Systematic Literature Identification: Primary data extraction from indexed clinical databases (PubMed, MEDLINE, EMBASE, and university clinical trials).
  2. Clinical Validity & Statistical Assessment: Scrutinizing sample sizes, blinding methods, p-values, and potential confounders in cited studies.
  3. Multi-Author Review: Cross-examination of drafts by independent editorial reviewers to prevent confirmation bias.
  4. Annual Systematic Audit: Continuous post-publication reviews to incorporate newly published guidelines or updated clinical consensus.
Non-Commercial Charter: Zenithstride is completely independent. We do not accept sponsored product placements, paid advertorials, or financial remuneration from pharmaceutical companies or dietary supplement manufacturers.

Corporate Registration & Registered Office

Company Legal Name UEL HOLDING AS
Norwegian Org. Number (Org.nr) 937 818 750
VAT / Tax ID NO937818750MVA
Registered Business Address Breivikveien 2B, 1394 Nesbru, Norway
Municipality & Jurisdiction 3203 Asker, Norway (Asker og Bærum tingrett)
Managing Director (Daglig leder) Ulf Eirik Larsen
Official Contact Email [email protected]